Latest News
Press background on Lasa Supergenerics Limited
Company profile
 Recent press releases
Lasa Supergenerics Resumes Operations in All Units Situated in Mahad and Chiplun

Lasa Supergenerics Limited, a vertically integrated group spanning the entire animal and human healthcare value chain has announced a calibrated restart of manufacturing operations in plants located at Mahad, Dist. Raigad. The Company managed to resume operations in units situated in Chiplu... (more)
Share
LASA Launches New Product - Oxyclozanide

Lasa Supergenerics Limited (BSE: 540702, NSE: LASA), pioneer and amongst the leading players in the manufacturing of Veterinary and Human APIs in India through its catalyst chemistry expertise and fully backward integrated unit, has added another product - Oxyclozanide to its portfolio of p... (more)
Share
Lasa Supergenerics Announces Robust PAT at Rs. 22.80 Crs, up 521 Percent YoY, with Recommendation of Dividend

Lasa Supergenerics Limited, a vertically integrated group spanning the entire animal and human healthcare value chain has announced its financial results for the fourth quarter and Financial Year ended March 31, 2021.
 
FY21 Performance overview compared with FY20
... (more)
Share
Lasa Supergenerics Q3FY21 PAT at 6.56 Crores up by 154% YoY Finance Cost Reduced by 95.40% YoY

Lasa Supergenerics Limited, a vertically integrated group spanning the entire animal and human healthcare value chain has announced its financial results for the third quarter ended December 31st 2020 (Q3FY21).
 
Q3FY21 performance overview compared with Q3FY20
... (more)
Share
LASA Receives WHO Nod for its Khed Unit in Ratnagiri

API major, Lasa Supergenerics Ltd. Received WHO Certificate of Good Manufacturing Practices from the Food and Drug Administration authorities for its manufacturing facility situated at Khed (Ratnagiri).
 
Commenting on the development, Dr. Omkar Herlekar, Chairman - Las... (more)
Share